FDA approves Novartis Cosentyx® as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade
31 oct. 2023 16h50 HE
|
Novartis Pharma AG
FDA approval based on robust Phase III data in which Cosentyx® (secukinumab) showed rapid relief from symptoms of hidradenitis suppurativa (HS) as early as Week 21 As the only IL-17A inhibitor...
Foundation for Sarcoidosis Research announces largest Global Sarcoidosis Virtual Summit – Find Your Community, Find Your Life
26 sept. 2023 09h15 HE
|
Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research to Host Largest Virtual Sarcoidosis Educational Event of the Year
Novartis remibrutinib Phase III trials met their primary endpoints and showed rapid symptom control in chronic spontaneous urticaria
09 août 2023 01h15 HE
|
Novartis Pharma AG
Ad hoc announcement pursuant to Art. 53 LR The Phase III REMIX-1 and REMIX-2 studies met all primary and secondary endpoints, showing rapid, clinically meaningful improvements across...
Global Pet Insurance Market Foreseen to Garner $28,377.8 Million, Growing at 15.3% CAGR in the 2021–2028 Timeframe [235-Pages] | Announced by Research Dive
20 avr. 2023 10h25 HE
|
Research Dive
New York, USA, April 20, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global pet insurance market. According to the report, the global market is projected to surpass...
With Expanded Outdoor Features, Lifestyle Healing Institute Integrates Traditional and Holistic Medicine
29 août 2022 08h04 HE
|
Lifestyle Healing Institute
NAPLES, Fla., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Lifestyle Healing Institute, a center for complementary and alternative medicine, treats illnesses with data-driven approaches delivered by a medical...
Growth: Significant Rise in the Adoption of Pets Across the Globe to Propel the Growth of the Global Pet Insurance Market [235-Pages] | Reveals by Research Dive
21 mars 2022 09h05 HE
|
Research Dive
New York, USA, March 21, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global pet insurance market is expected to generate a revenue of $28,377.8 million by 2028,...
The ASA and the NCCAOM Support the Acupuncture for Our Seniors Act
30 juil. 2021 15h22 HE
|
National Certification Commission for Acupuncture and Oriental Medicine
WASHINGTON, July 30, 2021 (GLOBE NEWSWIRE) -- The American Society of Acupuncturists (ASA) and the National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM) are pleased to...
Novartis presents positive Phase III results from JUNIPERA study supporting Cosentyx® as a potential treatment in a JIA population at EULAR 2021
02 juin 2021 01h15 HE
|
Novartis Pharma AG
Phase III JUNIPERA study met its primary endpoint, with Cosentyx® (secukinumab) showing significantly longer time to flare (longer time to worsening of symptoms1) vs. placebo (P<.001) in pediatric...
Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis
01 juin 2021 16h30 HE
|
Novartis Pharma AG
Approval for moderate to severe pediatric patients six years and older is based on pivotal trial data showing Cosentyx demonstrated superior improvements of skin symptoms compared to placebo1 The...
“Return to Life” Documentary Reveals Neuro-Acupuncture Success
28 mai 2021 14h14 HE
|
National Certification Commission for Acupuncture and Oriental Medicine
SANTA FE, N.M., May 28, 2021 (GLOBE NEWSWIRE) -- New documentary “Return to Life” premiered internationally via Zoom on Friday, May 7, 2021. From award-winning director Doug Dearth (“9000 Needles”),...